| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20067429 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20060307 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20021447 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20020950 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20060621 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20060716 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20045385 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20061144 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20060676 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS20033999 | HPV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIK2 |
|---|---|
| DrugBank ID | DB00142 |
| Drug Name | Glutamic acid |
| Target ID | BE0000826 |
| UniProt ID | Q13002 |
| Regulation Type | |
| PubMed IDs | 17581967 |
| Citations | Wong AY, MacLean DM, Bowie D: Na+/Cl- dipole couples agonist binding to kainate receptor activation. J Neurosci. 2007 Jun 20;27(25):6800-9. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Glutamic acid and derivatives |
| SMILES | N[C@@H](CCC(O)=O)C(O)=O |
| Pathways | Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling |
| PharmGKB | PA449776 |
| ChEMBL | CHEMBL575060 |
